Top Markets
#1 EXOD EXOD +9.04%
#2 MarsCoin MarsCoin +9.00%
#3 Akedo Akedo +8.33%
#4 Solstice Solstice +8.24%
#5 peaq peaq +8.13%
#6 ETHGas ETHGas +7.27%
#7 龙虾 (Lobster) 龙虾 (Lobster) +6.51%
#8 Wrapped Flare Wrapped Flare +6.34%
#9 Official Trump Official Trump +6.27%
#10 Peapods Finance Peapods Finance +6.22%
Coin of the day
EXOD EXOD
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Nanjing Leads Biolabs Co Ltd Nanjing Leads Biolabs Co Ltd

Nanjing Leads Biolabs Co Ltd

9887
Classement en actions #6832
Nanjing Leads Biolabs Co., Ltd. is a biotechnology firm currently in the... Nanjing Leads Biolabs Co., Ltd. is a biotechnology firm currently in the clinical development phase, dedicated to the global discovery, progression, and eventual market launch of innovative antibody-based medications. The company's therapeutic endeavors concentrate on various critical illnesses, including cancerous growths, autoimmune disorders, and other serious medical conditions. A prominent product in its development pipeline is LBL-024, a bispecific antibody engineered to target PD-L1 and 4-1BB, specifically for the treatment of extra-pulmonary neuroendocrine carcinoma. Other significant compounds under development include LBL-034, LBL-033, and LBL-007. Nanjing Leads Biolabs also leverages its proprietary LeadsBody platform, which focuses on CD3 T-cell engagers that have demonstrated promising anti-tumor effects and safety in preliminary studies, as well as the X-body platform, which specializes in 4-1BB/PD-L1 bispecific antibodies. Beyond these, the company is actively researching antibody treatments for oncological, autoimmune, and infectious diseases, and is also engaged in establishing tumor immunoassays. Established in 2012, its primary operations are based in Nanjing, China.
Prix de l'action
$9.29
Capitalisation boursière
$1.85B
Changement (1 jour)
0.83%
Changement (1 an)
21.96%
Pays
CN
Échange Nanjing Leads Biolabs Co Ltd (9887)

Catégorie

Healthcare
Historique des dividendes pour Nanjing Leads Biolabs Co Ltd (9887)
Nanjing Leads Biolabs Co Ltd (symbole boursier : 9887) a versé un total de 0 dividendes.
Le total des dividendes (ajusté en fonction des divisions d’actions) est de : 0.00
Rendement du dividende (TTM) : 0
Versements de dividendes pour Nanjing Leads Biolabs Co Ltd (9887) de 2026 à 2026
Versements annuels de dividendes
Année Dividende (ajusté pour divisions d’actions) Changez
Pas assez de données pour les dates fournies.
Liste de tous les paiements de dividendes
Année Dividende Changez
Pas assez de données pour les dates fournies.
Dividendes versés par des entreprises similaires ou concurrentes
Entreprise Nombre de paiements de dividendes Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH